Skip to main content

Table 6 Clinical importance and interest in participating study

From: Prophylactic antibiotic regimens in tumor surgery (PARITY) survey

  

No. (%)

 

Any reduction at all

15

(21.7%)

Amount an alternative antibiotic drug and regimen needs to reduce infection rate before the improvement is considered "clinically important"

5%

10

(14.5%)

10%

15

(21.7%)

15%

4

(5.8%)

20%

12

(17.4%)

25%

8

(11.6%)

30%

1

(1.4%)

35%

0

(0.0%)

40%

0

(0.0%)

50%

2

(2.9%)

>50%

2

(2.9%)

I would participate in a multi-centre randomized controlled study assessing different antibiotic regimens in long-bone reconstruction for tumor surgery.

Yes

61

(87.1%)

No

9

(12.9%)